drugset / Trial / NCT04026880

Testosterone Effects on Pelvic Floor Muscles

NCT04026880

Phase 3 Withdrawn Brigham and Women's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

An proof-of-concept study to determine whether administration of testosterone enanthate weekly results in greater improvements in structural and functional characteristics of pelvic floor muscles and urodynamic parameters in postmenopausal women with urinary incontinence than that associated with placebo administration

Timeline

Start
2021-01-01
Primary completion
2022-01-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Enanthate Small molecule 25 mg Intramuscular

Indications

No indication recorded.